Page last updated: 2024-08-26

phosphoramide mustard and Breast Neoplasms

phosphoramide mustard has been researched along with Breast Neoplasms in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bergh, J; Foukakis, T; Hatschek, T; Rydberg, P; Rydén, A; von Stedingk, H; Xie, H	1
Beijnen, JH; de Jonge, ME; Huitema, AD; Rodenhuis, S; van Dam, SM	1
Rekha, GK; Sladek, NE	1
Hansen, J; Jacobson-Kram, D; Kolodner, K; McDiarmid, MA; Strickland, PT	1

Trials

2 trial(s) available for phosphoramide mustard and Breast Neoplasms

Article	Year
Validation of a novel procedure for quantification of the formation of phosphoramide mustard by individuals treated with cyclophosphamide. Cancer chemotherapy and pharmacology, 2014, Volume: 74, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biomarkers, Pharmacological; Blood Chemical Analysis; Breast Neoplasms; Calibration; Cyclophosphamide; Female; Hemoglobins; Humans; Limit of Detection; Phosphoramide Mustards; Tandem Mass Spectrometry	2014
Population pharmacokinetics of cyclophosphamide and its metabolites 4-hydroxycyclophosphamide, 2-dechloroethylcyclophosphamide, and phosphoramide mustard in a high-dose combination with Thiotepa and Carboplatin. Therapeutic drug monitoring, 2005, Volume: 27, Issue:6 Topics: Adolescent; Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Carboplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Neoplasms; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Phosphoramide Mustards; Prodrugs; Thiotepa; Time Factors; Triethylenephosphoramide	2005

Article

Year

Validation of a novel procedure for quantification of the formation of phosphoramide mustard by individuals treated with cyclophosphamide.

Cancer chemotherapy and pharmacology, 2014, Volume: 74, Issue:3

Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biomarkers, Pharmacological; Blood Chemical Analysis; Breast Neoplasms; Calibration; Cyclophosphamide; Female; Hemoglobins; Humans; Limit of Detection; Phosphoramide Mustards; Tandem Mass Spectrometry

2014

Population pharmacokinetics of cyclophosphamide and its metabolites 4-hydroxycyclophosphamide, 2-dechloroethylcyclophosphamide, and phosphoramide mustard in a high-dose combination with Thiotepa and Carboplatin.

Therapeutic drug monitoring, 2005, Volume: 27, Issue:6

Topics: Adolescent; Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Carboplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Neoplasms; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Phosphoramide Mustards; Prodrugs; Thiotepa; Time Factors; Triethylenephosphoramide

2005

Other Studies

2 other study(ies) available for phosphoramide mustard and Breast Neoplasms

Article	Year
Inhibition of human class 3 aldehyde dehydrogenase, and sensitization of tumor cells that express significant amounts of this enzyme to oxazaphosphorines, by the naturally occurring compound gossypol. Advances in experimental medicine and biology, 1997, Volume: 414 Topics: Adenocarcinoma; Aldehyde Dehydrogenase; Antineoplastic Agents, Alkylating; Breast Neoplasms; Catechols; Cell Survival; Cyclophosphamide; Enzyme Induction; Female; Gastric Mucosa; Gossypol; Humans; Kinetics; Phosphoramide Mustards; Recombinant Proteins; Substrate Specificity; Tumor Cells, Cultured	1997
Baseline and phosphoramide mustard-induced sister-chromatid exchanges in cancer patients treated with cyclophosphamide. Mutation research, 1990, Volume: 241, Issue:3 Topics: Breast Neoplasms; Cells, Cultured; Female; Humans; Leukemia; Lymphocytes; Male; Neoplasms; Phosphoramide Mustards; Reference Values; Sister Chromatid Exchange	1990

Article

Year

Inhibition of human class 3 aldehyde dehydrogenase, and sensitization of tumor cells that express significant amounts of this enzyme to oxazaphosphorines, by the naturally occurring compound gossypol.

Advances in experimental medicine and biology, 1997, Volume: 414

Topics: Adenocarcinoma; Aldehyde Dehydrogenase; Antineoplastic Agents, Alkylating; Breast Neoplasms; Catechols; Cell Survival; Cyclophosphamide; Enzyme Induction; Female; Gastric Mucosa; Gossypol; Humans; Kinetics; Phosphoramide Mustards; Recombinant Proteins; Substrate Specificity; Tumor Cells, Cultured

1997

Baseline and phosphoramide mustard-induced sister-chromatid exchanges in cancer patients treated with cyclophosphamide.

Mutation research, 1990, Volume: 241, Issue:3

Topics: Breast Neoplasms; Cells, Cultured; Female; Humans; Leukemia; Lymphocytes; Male; Neoplasms; Phosphoramide Mustards; Reference Values; Sister Chromatid Exchange

1990